Association Between Muscle L3 CT Scan Muscle Derived Parameters of Muscle Function Upon Intensive Care Unit Admission and 3 Months Mortality After ICU Discharge for Patients Admitted for Septic Shock. The SIMS Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Evaluation of muscle dysfunction in intensive care units for septic schock patients: Correlation between muscle L3 CT scan muscle derived parameters of muscle function upon intensive care unit admission and 3 months mortality after ICU discharge for patients admitted for septic shock
Study summary
Muscle dysfunction in intensive care units is associated with significant morbidity and mortality. During septic shock, there is an increased catabolism and systemic inflammation resulting in quantitative and qualitative muscle impairment. In the intensive care setting, quantitative and qualitative assessment of muscle function is challenging due to critical care environments (general anesthesia, altered consciousness, etc.). CT scan measurement at the 3rd lumbar level has been proposed to evaluate muscle function. Recent retrospective studies have highlighted increased mortality among patients with muscle mass impairment and/or decreased muscle density.
Eligibility
Primary outcome measure(s)
- vital status — 90 days
alive or dead - Total muscle mass measured at L3 (cm²/m² ) — at inclusion
Total muscle mass measured at L3 by CT scan, normalized by patient height (Skeletal Muscle Index), in cm²/m² upon admission to the ICU (Correlation between three L3 CT scan parameters of muscle function upon admission to the intensive care unit and the risk of mortality at 3 months after ICU discharge in septic shock patients). - Total muscle density measured at L3 ( Hounsfield Unit) — at inclusion
\- Total muscle density measured at L3 by CT scan (Skeletal Muscle Density) in HU upon admission to the ICU (Correlation between three L3 CT scan parameters of muscle function upon admission to the intensive care unit and the risk of mortality at 3 months after ICU discharge in septic shock patients). - Total fat excretion fraction measured at L3 (%) — at inclusion
Total fat excretion fraction measured at L3 (Fat Fraction) by CT scan upon admission to the ICU (Correlation between three L3 CT scan parameters of muscle function upon admission to the intensive care unit and the risk of mortality at 3 months after ICU discharge in septic shock patients).
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospices Civils de Lyon | Lyon | France | Not Yet Recruiting |
| AP HM, Hôpital La Timone | Marseille | France | Not Yet Recruiting |
| Clinique Mutualiste | Saint-Etienne | France | Not Yet Recruiting |
| Centre Hospitalier Universitaire de Saint-Etienne | Saint-Etienne | France | Recruiting |
More Centre Hospitalier Universitaire de Saint Etienne trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07483710 on ClinicalTrials.gov ↗ ← All trials in France